inflammatory bowel disease Adaptive Biotechnologies Making Inroads in MRD, Immune Medicine Businesses Premium The Seattle-based company recently completed a strategic reorganization around its two major business areas by cutting the workforce and appointing a new CFO. Adaptive Biotechnologies Makes Progress Toward T-Cell Assay for Inflammatory Bowel Disease Premium The Seattle-based company recently published immune repertoire data showing the potential of T-cell receptor profiling in IBD diagnostics. Adaptive Biotechnologies to Focus on Immune Medicine, Minimal Residual Disease Testing Businesses Premium The Seattle-based company said this week that its immune medicine and minimal residual disease testing business arms will drive the firm's future growth. Coral Genomics, Crohn's & Colitis Foundation Partner on Study of IBD Treatment Response San Francisco-based Coral will study up to 1,000 patients in an IBD cohort as it develops a test to predict patient response to treatment. Roche, Mimetas Partner to Develop Disease Models for Drug Discovery The companies are doing research to characterize novel drug compounds in inflammatory bowel disease and hepatitis B virus. Jun 15, 2021 Norwegian Firm Genetic Analysis Awarded $1.9M to Develop Microbiome Test for IBD Treatment May 6, 2021 Coral Genomics Bets on Diverse Data to Advance Precision Medicine for Autoimmune Disease Premium Mar 31, 2021 Human Gut Microbiome Continues to Develop Through Early Childhood Mar 12, 2021 Prometheus Biosciences Prices Upsized $190M IPO Feb 17, 2021 Inflammatory Bowel Disease Genetic Risk Architecture Appears Distinct in African Americans Jan 19, 2021 ABO Histo-Blood Groups Influence Makeup of Gut Microbiome, New Study Finds Dec 24, 2020 IBD Polygenic Risk Scores Improved With Data From Multiple Ancestral Backgrounds Dec 8, 2020 Single-Cell Transcriptome Study Links Gut Development, Pediatric Crohn's Disease Oct 6, 2020 Startup Coral Genomics Wins $2M SBIR Grant From NIH Sep 2, 2020 BiomX, Boehringer Ingelheim Partner for Inflammatory Bowel Disease Biomarker Discovery Aug 21, 2020 Single-Cell Analysis Reveals Ulcerative Colitis Tissue, Immune Features Aug 13, 2020 Scipher Medicine, Galapagos Sign IBD Drug Development Deal Jul 21, 2020 Inflammatory Bowel Disease Study Points to Role For Somatic Colon Mutations Jul 13, 2020 Genuity Science, Formerly WuXi NextCode, Reinvents Itself With US, Europe Focus Premium Jul 1, 2020 Celsius Therapeutics Teams With Oxford, Cleveland Clinic, LMU on Single-Cell IBD Research Apr 6, 2020 Gilead Sciences, Second Genome Partner for Microbiome-Based IBD Biomarker, Drug Discovery Feb 3, 2020 IMIDomics, Gossamer Bio Form Immune-Mediated Inflammatory Disease Alliance Oct 22, 2019 KSL Biomedical to Commercialize PredictImmune IBD Test in North America Oct 4, 2019 Prometheus Biosciences, Takeda Pharmaceutical to Codevelop Targeted Therapies, CDx for IBD Jul 30, 2019 PredictImmune Closes £10M Series B Financing Round Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.